24 operations-management-associate-professor Fellowship positions at University of London
Sort by
Refine Your Search
-
Assistant Professor) to support primarily two new UKRI projects with additional ad hoc statistical analysis and epidemiological interpretation for projects in the thriving laboratories of Professor Chris
-
of Health and Care Excellence. The appointment can be at Research Fellow or Assistant Professor level, depending on applicant background. The post-holder will lead innovative research projects related
-
Department of Health Services Research and Policy to work a study called Timeliness of access to Cancer Treatment - improving care (TACTIC) https://fundingawards.nihr.ac.uk/award/NIHR168433 , a NIHR-funded
-
to work in Professor Polly Roy’s dynamic and productive research laboratory at LSHTM. The post is funded by Wellcome Trust and is focused on double-stranded RNA virus replication. Applicants should be
-
Mortality and Inequalities Research Group and work closely with Associate Professor José Manuel Aburto and the Population Studies Group at LSHTM. The post-holder’s primary role will be to provide support for
-
November 2025. The post is funded by the ESRC (Economic and Social Research Council), as part of the ESRC Centre for Care, and is available from 01 June 2025. The appointee will work with Professor Shereen
-
Right to work: Applications from job seekers who require sponsorship to work in the UK are welcome and will be considered alongside all other applications. For further information visit the UK Visas
-
-year Postdoctoral Fellowship in Planetary Health, on a scheme run jointly by LSHTM’s Centre on Climate Change and Planetary Health and Stanford University’s Center for Human and Planetary Health
-
of Ghana School of Public Health (UGSPH). The post will be managed by Dr Chido Dziva Chikwari and Dr Rachel Scott, the MSc SRHPP co-Programme Directors. Applicants must have a postgraduate degree, ideally a
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving